期刊文献+

联合应用磁共振动态增强及弥散加权成像对乳腺癌的诊断价值 被引量:9

Clinical Application of Combined Application of Diffusion-weight MRI and Dynamic Contrast Enhancement on the Diagnosis of Breast Cancer
下载PDF
导出
摘要 目的:探讨联合应用磁共振动态增强及弥散加权成像对乳腺癌的诊断价值。材料与方法:对临床门诊发现有乳腺肿块的80名女性患者(良性肿瘤40例,恶性肿瘤40例),采用德国西门子Avanto 1.5T超导磁共振扫描仪对所有患者首先行MRI动态增强扫描,包括平扫T1W1,T2W1,Flash-3D动态增强扫描,分别对良恶性病变的形态学特征与动态增强表现进行评估,绘制病变的时间-信号强度曲线,判断诊断敏感性、特异性;后行弥散加权成像,计算弥散加权成像在不同b值时乳腺良性、恶性肿瘤ADC值,利用ROC曲线判定诊断阈值,敏感性、特异性;最后动态MRI动态增强扫描及弥散加权成像联合对肿瘤良恶性进行判断,与手术病理结果相对照,研究联合应用磁共振动态增强及弥散加权成像对乳腺癌诊断的敏感性和特异性。结果:乳腺良恶性肿瘤MRI信号表达间无明显差异;动态增强扫描中,乳腺恶性肿瘤多为Ⅱ、Ⅲ曲线,乳腺良性肿瘤多为Ⅰ、Ⅱ曲线,差异有显著意义(P<0.05),诊断敏感度为90%,特异度为60%。磁共振弥散加权成像在不同b值下(b值分别取400,800s/mm2),当b值400 s/mm2时,灵敏度为82.5%,特异度为80%,b=800s/mm2时,灵敏度为92.65%,特异度为70%。随着特异度的升高,灵敏度下降。二者联合应用敏感性为80%,特异性为92.5%。结论:临床在诊断乳腺恶性肿瘤方面,动态增强扫描虽然能够较为准确区分,但是特异度较低;弥散加权信号特异度高,但是敏感度相对较差,实际应用过程中应当将二者结合起来,提高诊断特异度。 Purpose: To evaluate the clinical application of combined diffusion-weight imaging (DWI) and dynamic contrast enhancement in the diagnosis of breast cancer. Materials and Methods: 80 female patients containing 40 eases of begin and 40 cases of malignant breast lumps received MRI dynamic contrast-enhanced scans by Germany's Siemens Avanto 1.5T superconducting MRI scanner, including plain TIW1, T2WI, and Flash-3D dynamic contrast-enhanced scans, respectively. And then, lesion time-signal intensity curve were used to evaluate the diagnostic sensitivity and specificity. ADC values of diffusion-weighted imaging are calculated at different b values of benign and malignant tumors and then we use ROC curves to determine the diagnostic threshold, sensitivity, specificity. Finally Dynamic MRI scanning and dynamic contrast- enhanced diffusion-weighted imaging combined to judge the benign or malignant tumor, and then compared the different images with final pathological diagnosis to to determine the diagnostic threshold, sensitivity, specificity. Results: Benign and malignant mammary tumor could be tested in conventional MRI, but with poor effects in the distinction of benign and malignant mammary tumor. The dynamic contrast enhancement can accurately distinguish benign and malignant breast tumor, but with low specificity. Apparent Diffusion Coefficient ( ADC ) value of normal lesion, benign tumor, and malignant tumor was statistically analyzed. With b value of 400s/mm^2, the sensitivity, specificity was 82. 5%, 80%. With b value of 800s/mm^2, the sensitivity, specificity was 92. 65% , 70%. When combined the two test together, sensitivity, specificity was 80% , 92. 5%. Condusion: We should have combined application of DWI and ADC to increase the sensitivity, specificity of breast tumor.
作者 鱼汀 李国华
出处 《现代医用影像学》 2015年第1期38-43,共6页 Modern Medical Imageology
基金 常熟市科技项目计划任务书(cs 201226)
关键词 磁共振弥散加权成像 动态增强扫描 乳腺癌 Diffusion-weight MRI Dynamic contrast enhancement Breast cancer
  • 相关文献

参考文献10

  • 1汪晓红,彭卫军,谭红娜,信超,顾雅佳,唐峰,毛健.磁共振弥散加权成像监测乳腺癌新辅助化疗疗效的应用价值[J].中华肿瘤杂志,2010,32(5):377-381. 被引量:33
  • 2谢洁林,汪登斌,陈克敏.乳腺磁共振扩散成像表观弥散系数值差异的比较研究[J].外科理论与实践,2008,13(2):126-129. 被引量:15
  • 3Ko E Y, HanA P, Shin JH, et al. BreastMRI forevaluating patientswithmetastatic axillary lymph node and initially nega- tive mammography and sonography [ J ]. Korean JRadio, 2007, 8 (5) : 382-389.
  • 4Sharma U, Danishad KKA, Seenu V, et al. Longitudinal study of the assessment by MRI and diffusion-weighted ima- ging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy [ J]. NMR Biomed, 2009, 22(1): 104 - 113.
  • 5Richard G Abramson, Lori R Arlinghaus, et al. Current and emerging quantitative magnetic resonance imaging methods forassessing and predicting the response of breast cancer to neo- adjuvant therapy[J]. Breast Cancer (London), 2012, 2012 (4): 139 - 154.
  • 6Jensen LR, Garzon B, Heldahl MG, et al. Diffusion-weigh- ted and dynamic contrast-enhanced MRI in evaluation of early treatment effects during neoadjuvant chemotherapy in breast cancer patients[J]. J Magn Reson Imaging, 2011, 34(5): 1099 - 1109.
  • 7Neehifor-Boila IA, Bancu S, Buruian M, et al. Diffusion Weighted Imaging with Background Body Signal Suppression/ T2 Image Fusion in Magnetic Resonance Mammography for Breast Cancer Diagnosis [ J]. Chirurgia, 2013, i08 (2) : 199-205.
  • 8Yankeelov TE, Gore JC. Dynamic contrast enhanced magnet- ic resonance imaging in oncology: theory, data acquisition, a- nalysis, and examples[J]. Curr Med Imaging Rev, 2009, 3 (2): 91 - 107.
  • 9Atuegwu NC, Colvin DC, Loveless ME, et al. Incorporation of diffusion-weighted magnetic resonance imaging data into a simple mathematical model of tumor growth[ J]. Phys Med Bi- ol, 2012, 57(1): 225 - 240.
  • 10Atuegwu NC, Arlinghaus LR, Li X, et al. Integration of dif- fusion-weighted MRI data and a simple mathematical model to predict breast tumor cellularity during neoadjuvant chemother- apy[J]. Magn Reson Med, 2011, 66(6) : 1689 - 1696.

二级参考文献35

  • 1蔡世峰,赵斌,王光彬,于台飞.不同类型正常乳腺表观扩散系数值差异的研究[J].中华放射学杂志,2007,41(2):176-179. 被引量:12
  • 2Therasse P,Attack SC,Eisenhauer EA,el al.New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,National Cancer Institute of Canada.J Natl Cancer Inst,2000,92:205-216.
  • 3Moffat BA,Hall DE,Stojanovska J,et al.Diffusion imaging for evaluation of tumor therapies in preclinical animal models.Magn Reson Mater Phys Biol Med,2004,17:249-259.
  • 4Hall DE,Moffat BA,Stojanovska J,et al.Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.Clin Cancer Res,2004,10:7852-7859.
  • 5Lee KC,Hall DE,Hoff BA,et al.Dynamic imaging of emerging resistance during cancer therapy.Cancer Res,2006,66:4687-4692.
  • 6Jennings D,Hatton BN,Guo J,et al.Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI.Neoplasia,2002,4:255-262.
  • 7Plaks V,Koudinova N,Nevo U,et al.Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD:a biphasic apparent diffusion coefficient change as potential early MRI response marker.Neoplasia,2004,6:224-233.
  • 8Chenevert TL,Meyer CR,Moffat BA,et al.Diffusion MRI:a new strategy for assessment of cancer therapeutic efficacy.Mol Imaging,2002,1:336-343.
  • 9Ross BD,Moffat BA,Lawrence TS,et al.Evaluation of cancer therapy using diffusion magnetic resonance imaging.Mol Cancer Ther,2003,2:581-587.
  • 10Guo Y,Cai YQ,Cai ZL,et al.Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging.J Magn Reson Imaging,2002,16:172-178.

共引文献45

同被引文献80

引证文献9

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部